COVID-19 Drug Information

Drug General Information

Drug ID

D0R1VR

Drug Name

Fluphenazine

Synonyms

FLUPHENAZINE; Triflumethazine; Fluorophenazine; Fluorphenazine; Fluorfenazine; Siqualon; Elinol; 69-23-8; Phthorphenazine; Vespazine; Ftorphenazine; Siqualine; Sevinol; Pacinol; Fluphenazinum; Flufenazina; Prolixin; Flufenazin; Dapotum; Flufenazina [DCIT]; Yespazine; SQ 4918; Fluphenazine [INN:BAN]; Moditen (Tabl or elixir); Fluphenazinum [INN-Latin]; 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol; 10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine; UNII-S79426A41Z; HSDB 3334; Dapotum; Prolixine; Fluphenazine hydrochloride; Moditen Hcl; Permitil Concentrate; Prolixin Concentrate; S94; Anatensol (TN); Apo-Fluphenazine; Dapotum (TN); Dapotum D (TN); Dapotum Injektion (TN); Decanoate (TN); Deconoate (TN); Enanthate (TN); Fludecate (TN); Flunanthate (TN); Fluphenazine (INN); Hydrochloride, Fluphenazine; Lyogen (TN); Modecate (TN); Moditen (TN); Moditen Enanthate Injection (TN); Omca (TN); Permitil (TN); Prolixin (TN); Sediten (TN); Selecten (TN); Sevinol (TN); Sinqualone (TN); Trancin (TN)

Drug Type

Small molecular drug

Indication

Middle East Respiratory Syndrome (MERS)

Investigative

[1]

Severe acute respiratory syndrome (SARS)

Investigative

[1], [2]

Therapeutic Class

Antiviral Agents

Company

Bristol-Myers Squibb

Structure

Download

2D MOL

3D MOL

Formula

C22H26F3N3OS

Canonical SMILES

C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO

InChI

1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2

InChIKey

PLDUPXSUYLZYBN-UHFFFAOYSA-N

CAS Number

CAS 69-23-8

PubChem Compound ID

3372

PubChem Substance ID

9223, 606306, 841998, 5329924, 7979286, 8152146, 10532904, 11111179, 11111180, 11212325, 11335686, 11360925, 11363183, 11364798, 11365745, 11367360, 11368307, 11369922, 11372419, 11372962, 11374514, 11375522, 11376469, 11378089, 11461897, 11466348, 11467468, 11485013, 11486275, 11489015, 11491235, 11492643, 11494103, 14832617, 24263032, 26751625, 29222507, 46506645, 47291093, 47291094, 47365145, 47588956, 47588957, 47662238, 47662239, 47736435, 47885368, 48110419, 48259193, 48259194

ChEBI ID

CHEBI:5123

Target

Top

Target(s)

HUMAN clathrin-mediated endocytosis (RME)

Target Info

Inhibitor

[1], [2]

Neurotransmitter inhibitor fluphenazine exhibits inhibitory activity against clathrin-mediated endocytosis of MERS-CoV (IC50 = 3.23 microM) and SARS-CoV (EC50 = 21.431 microM).

References

Top

Testing of Middle East respiratory syndrome coronavirus replication inhibitors for the ability to block viral entry. Antimicrob Agents Chemother. 2015 Jan;59(1):742-4.

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Download

Prof. Feng ZHU

Prof. Yuzong CHEN